Skip to main content
Genus PLC logo

Genus PLC — Investor Relations & Filings

Ticker · GNS ISIN · GB0002074580 LEI · 54930022EOITNKSIGH56 IL Agriculture, forestry and fishing
Open in API
Filings indexed 532 across all filing types
Latest filing 2016-06-17 Regulatory Filings
Country GB United Kingdom
Listing IL GNS

About Genus PLC

http://www.genusplc.com/

Genus PLC is a world-leading animal genetics company that pioneers genetic improvement in livestock. The company applies cutting-edge science and biotechnology to help farmers in the dairy, beef, and pork sectors breed more productive and healthier animals. It operates through two primary businesses: ABS, which provides bovine (cattle) genetics, and PIC, which provides porcine (pig) genetics. By supplying elite genetic material, Genus enables farmers to produce high-quality milk and meat more efficiently and sustainably. The company's focus on genetic advancement also aims to improve animal wellbeing and reduce the need for antibiotics, contributing to a more sustainable global food system.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1174 characters) and contains an RNS Number (6055B) from the London Stock Exchange. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific operational announcement concerning market mechanics rather than a comprehensive financial report (like 10-K or IR) or a standard corporate action (like DIV or ER). Since it is a direct, non-standard regulatory announcement from the exchange's news service (RNS), and it doesn't fit the specific definitions for AGM-R, 10-K, ER, DIV, etc., the most appropriate classification is the general regulatory filing fallback category, RNS.
2016-06-17 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1157 characters) and announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange, identified by the 'RNS Number : 6042B'. The text explicitly states, 'This information is provided by RNS The company news service from the London Stock Exchange'. This indicates a general regulatory announcement or market notice that does not fit the specific financial report categories (like 10-K, ER, IR) or specific corporate actions (like DIV, DIRS, MANG). Therefore, the most appropriate classification is the general regulatory filing/announcement category.
2016-06-17 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is very short (1015 characters) and explicitly states it is an 'RNS Number' announcement from the London Stock Exchange. The content announces the 'TOTAL VOTING RIGHTS' (61,007,954 ordinary shares) and specifies this figure is for shareholders to use under the FCA's Disclosure and Transparency Rules. This type of mandatory, short regulatory update regarding share capital structure and voting rights, especially when explicitly labeled as an RNS, fits best under the general 'Regulatory Filings' category (RNS) as it is not a specific report like 10-K, AR, or a specific announcement like DIV or DIRS, although it relates to share capital. However, given the specific nature of announcing the total number of shares for voting rights calculation, it is a regulatory disclosure. Since 'RNS' is defined as the fallback for miscellaneous regulatory filings, and this is a standard regulatory disclosure, RNS is the most appropriate code.
2016-06-01 English
Exclusive Licence for Leading Gene Editing Tech
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and the date '18 May 2016', followed by 'FOR IMMEDIATE RELEASE'. The content describes a strategic collaboration and exclusive license agreement between Genus plc and Caribou Biosciences regarding CRISPR-Cas9 technology in livestock. This type of announcement, which details a significant business development (a major partnership/licensing deal) and is disseminated via the Regulatory News Service (RNS) system of the London Stock Exchange, fits best under the general regulatory announcement category. Since it is not a formal financial report (10-K, IR, ER), a management change (MANG), or a capital event (CAP, SHA), the most appropriate classification is RNS, which serves as the general regulatory filing category for such news releases.
2016-05-18 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is very short (1013 characters) and explicitly states it is providing 'Additional information' via an 'RNS Number'. The content details the 'TOTAL VOTING RIGHTS' (61,001,097 ordinary shares) and serves as the denominator for shareholders calculating their notification requirements under the FCA's Disclosure and Transparency Rules. This type of mandatory, short regulatory update regarding share capital structure and voting rights, especially when disseminated via RNS, fits best under the category for official regulatory announcements that don't fit a more specific financial report type. While it relates to share capital, it is a notification of the total count, not a transaction (POS) or a general capital change announcement (SHA). Given the context of being an RNS release providing essential regulatory data, 'Regulatory Filings' (RNS) is the most appropriate fallback, although 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is a close second. However, DVA is typically for the *results* of a vote, whereas this is the *denominator* for future voting calculations. Therefore, RNS is chosen as the general regulatory announcement category.
2016-05-03 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document text explicitly contains the header "RNS Number : 9553T" and details a transaction involving shares purchased by a Director/PDMR (Catherine Glickman, Group Human Resources Director). This directly corresponds to the definition of Director's Dealing (insider trades). The filing code for Director's Dealing is DIRS. The document is short and appears to be a direct regulatory notification, not an announcement of a larger report.
2016-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.